262 related articles for article (PubMed ID: 26303110)
21. A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy.
Chen Y; Xu S; Wang Z; Zhao M; Wang H; Lu T; Zhao L
Ther Drug Monit; 2018 Dec; 40(6):730-737. PubMed ID: 30169477
[TBL] [Abstract][Full Text] [Related]
22. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients.
Sun YX; Zhuo WY; Lin H; Peng ZK; Wang HM; Huang HW; Luo YH; Tang FQ
Epilepsy Res; 2015 Aug; 114():78-80. PubMed ID: 26088889
[TBL] [Abstract][Full Text] [Related]
23. Clinically Relevant Effect of UGT1A4*3 on Lamotrigine Serum Concentration Is Restricted to Postmenopausal Women-A Study Matching Therapeutic Drug Monitoring and Genotype Data From 534 Patients.
Smith RL; Haslemo T; Chan HF; Refsum H; Molden E
Ther Drug Monit; 2018 Oct; 40(5):567-571. PubMed ID: 30086088
[TBL] [Abstract][Full Text] [Related]
24. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X
J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113
[TBL] [Abstract][Full Text] [Related]
25. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
[TBL] [Abstract][Full Text] [Related]
26. Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients.
Yamamoto Y; Inoue Y; Matsuda K; Takahashi Y; Kagawa Y
Biol Pharm Bull; 2012; 35(4):487-93. PubMed ID: 22466551
[TBL] [Abstract][Full Text] [Related]
27. Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1999 Apr; 21(2):175-81. PubMed ID: 10217337
[TBL] [Abstract][Full Text] [Related]
28. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
[TBL] [Abstract][Full Text] [Related]
29. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X
PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607
[TBL] [Abstract][Full Text] [Related]
30. No association between non-bullous skin reactions from lamotrigine and heterozygosity of UGT1A4 genetic variants *2(P24T) or *3(L48V) in Norwegian patients.
Shirzadi M; Reimers A; Helde G; Sjursen W; Brodtkorb E
Seizure; 2017 Feb; 45():169-171. PubMed ID: 28068583
[TBL] [Abstract][Full Text] [Related]
31. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
32. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F
Gene; 2024 Jan; 892():147886. PubMed ID: 37820941
[TBL] [Abstract][Full Text] [Related]
33. Lamotrigine and valproate pharmacokinetics interactions in epileptic patients.
Lalic M; Cvejic J; Popovic J; Bozic K; Golocorbin-Kon S; Al-Salami H; Mikov M
Eur J Drug Metab Pharmacokinet; 2009; 34(2):93-9. PubMed ID: 19645218
[TBL] [Abstract][Full Text] [Related]
34. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy.
Klarica Domjanović I; Lovrić M; Trkulja V; Petelin-Gadže Ž; Ganoci L; Čajić I; Božina N
Br J Clin Pharmacol; 2018 Sep; 84(9):2106-2119. PubMed ID: 29791014
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of the Influence of UGT Genetic Polymorphisms on Lamotrigine Concentration.
Kim SC; Kim MG
Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):163-169. PubMed ID: 30168665
[TBL] [Abstract][Full Text] [Related]
36. Does lamotrigine influence valproate concentrations?
Mataringa MI; May TW; Rambeck B
Ther Drug Monit; 2002 Oct; 24(5):631-6. PubMed ID: 12352935
[TBL] [Abstract][Full Text] [Related]
37. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP
Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391
[TBL] [Abstract][Full Text] [Related]
38. Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine.
Reimers A; Sjursen W; Helde G; Brodtkorb E
Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):149-55. PubMed ID: 25492569
[TBL] [Abstract][Full Text] [Related]
39. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
[TBL] [Abstract][Full Text] [Related]
40. Influence of uridine diphosphate glucuronosyltransferase inducers and inhibitors on the plasma lamotrigine concentration in pediatric patients with refractory epilepsy.
Yamamoto Y; Takahashi Y; Imai K; Ikeda H; Takahashi M; Nakai M; Inoue Y; Kagawa Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):214-20. PubMed ID: 25825021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
